Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomised, Open-labeled, Parallel Group Study to Assess the Efficacy and Safety of Low Dose Ticagrelor Compared With Standard Dose Ticagrelor in Patients With Unstable Angina Pectoris After Drug Eluting Stent Implantation

NCT03620760 is registered in ClinicalTrials.gov with Xiaofan Wu as lead sponsor.

NCT NCT03620760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomised, Open-labeled, Parallel Group Study to Assess the Efficacy and Safety of Low Dose Ticagrelor Compared With Standard Dose Ticagrelor in Patients With Unstable Angina Pectoris After Drug Eluting Stent Implantation
Lead sponsor
Xiaofan Wu
Phase
Phase 4
Overall status
Unknown status
Start date
August 7, 2018
Completion date
December 31, 2020
Enrollment
2,036 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stent implantation, unstable angina pectoris